RMTI
ROCKWELL MEDICAL, INC.
Key Financials
Operating Income
$-4691000
↓ 871.5%
Gross Profit
$11.7M
↓ 33.1%
Net Income
$-5314000
↓ 1007.1%
Total Liabilities
$20.2M
↓ 24.3%
Total Assets
$57.1M
↓ 3.5%
EPS (Diluted)
$-0.15
↓ 400.0%
Cash & Equivalents
$10.7M
↓ 31.6%
Shareholders' Equity
$37.0M
↑ 13.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| DEFA14A | 5/11/2026 | View on SEC |
| 8-K | 5/8/2026 | View on SEC |
| 8-K | 5/7/2026 | View on SEC |
| 10-Q | 5/7/2026 | View on SEC |
| 8-K | 5/7/2026 | View on SEC |
| ARS | 4/30/2026 | View on SEC |
| DEF 14A | 4/30/2026 | View on SEC |
| PRE 14A | 4/20/2026 | View on SEC |
| 4/A | 4/17/2026 | View on SEC |
| 4/A | 4/17/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | RMTI |
| Company Name | ROCKWELL MEDICAL, INC. |
| CIK | 1041024 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 8004493353 |